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Figure taken from: http://www.curehits.com/drug-resistant-staph-infections-antibiotic-resistant-strains-staphylococcus-aureus/ 
Figure taken from: https://www.youtube.com/watch?v=gvFo61NJ3ds 
Infectious Disease Society of America 
2014: 9 of the 10 leading cause of disease: infectious 
Figure taken from : http://www.compoundchem.com/2014/09/08/antibiotics/ 
 Classes of Antibiotics 
•  Resistance is rare 
peptide: made from amino acids 
Structure of lipopeptides 
lipid: nonpolar tail 
Lipopeptide Mechanism of Action 
By destroying the cell membrane 
Lipopeptide Mechanism of Action 
cholesterol 




X-(L-Orn)n-NH2   
myr-L-Orn-L-Orn-L-Orn-NH2   
D and L Amino Acids 
Figure taken from : https://www.u-tokyo.ac.jp/en/utokyo-research/editors-choice/researchers_serendipities_pave_way_for_waste_free_drug_synthesis.html 
L-amino acid D-amino acid 
L-Orn D-Orn 
cv 
Substituting L-Amino Acid Residues  
with D-Amino Acid Residues 
Statement of the Problem 
Evaluate if a lipopeptide containing D-ornithine 
residues has better antimicrobial activity           
compared to its L-ornithine derivative 
myr-L-Orn-L-Orn-L-Orn-NH2  myr-D-Orn-D-Orn-D-Orn-NH2 
Figure taken from : https://www.u-tokyo.ac.jp/en/utokyo-research/editors-choice/researchers_serendipities_pave_way_for_waste_free_drug_synthesis.html 
Objectives 




Preparation of:  
myr-L-Orn-L-Orn-L-Orn-NH2  
myr-D-Orn-D-Orn-D-Orn-NH2  
Test antimicrobial activity against: 
E. coli  S. aureus  
Evaluation of activity against: 
E. coli  S. aureus  
1 •  Synthesis on solid phase  
2 
•  Purification and 
Characterization 
3 
•  Determination of  activity 














•  Using free amino acids lead to mixtures 
Peptide Synthesis 
             Product 1         Product 2 AA1 -  AA2 
AA2 - AA1 
AA1 – AA2 
AA2 – AA2 















•  Using amino acids with protecting groups 
Directed Peptide Synthesis 
•  Form only the desired  product 
NH2- 
Myr-H 
Solid Phase Peptide Synthesis 
“for his development
 of methodology for  
  chemical synthesis 
   on a solid matrix” 
Bruce     
Merrifield 
Solid matrix 
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Solid Phase Peptide Synthesis 
“for his development
 of methodology for  
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   on a solid matrix” 
Bruce     
Merrifield 
Resin 
Solid Phase Peptide Synthesis 
“for his development
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1 •  Synthesis on solid phase  
2 
•  Purification: HPLC 
•  Characterization: UV; Mass 
Spectrometry; CD 
3 
•  Determine MIC E. coli 
•  Determine MIC S. aureus 
Methodology 




Attached myristic id at N-
terminal 
Cleaved lipopepide from 
resin 
























Couple with Myr 
Cleave with TFA:TIS:H2O 
H2N- Bromophenol Test 
Blue Beads: Free amine Clear Beads: No free amine 
Monitoring the       
SPP Synthesis 
 
1 •  Synthesized lipopeptide  
2 
•  Purified: HPLC 
•  Characterized: UV; Mass 
Spectrometry; CD 
3 
•  Determined MIC against   E. 
coli and S. aureus 
Methodology 
Figure taken from: https://www.shine.cn/archive/world/WHO-ranks-antibiotics-in-a-bid-to-counter-drug-resistance/shdaily.shtml 
 Results and Discussion 
UV spectra of Fmoc                  
deprotection solution 
















•  HPLC Chromatogram 
•  UV Detector: 215; Reverse Phase 
























 Against E. coli &     
   and    S. aureus 
Broth Dilution Assay 






































 Decreasing concentration of lipopeptide  
(MIC) Minimum 
Inhibitory Concentration 
MIC Values of 
Lipopeptides 
Minimum Inhibitory
 Concentration  























•  Which will be more     st
able with trypsin? 
Future 
Work 
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New Lipopeptides: 
Echinocandins 
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Coupling with HOAt / HATU 
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Couple with Myr 
Cleave with TFA:TIS:H2O 
H2N- 
























Couple with Myr 
Cleave with TFA:TIS:H2O 
H2N- 
























Couple with Myr 
Cleave with TFA:TIS:H2O 
H2N- 





L sugar  versus L  and L amino acid  
O O 
Eukaryotic vs Bacteria Membrane 
- - - - - 
- - - - - - - - - - 
































Couple with Myr 
Cleave with TFA:TIS:H2O 
H2N- 
Questions1 
What are the advantages of solid phase synthesis? 
What is the advantage of the Fmoc strategy vs Boc 
strategy? Use of HF 
Mechanism of Fmoc Deprotection 
What is piperidine? 
Mechanism of HOBT/ HBTU coupling 
What is coupling reagent for? 
What is HBTU? 
What is HOBt Mechanism of coupling? 
What is DIEA for? 
Mechanism of TFA cleavage 
What us L and D lipopeptide? 
Requirement to be chiral 
How distinguish L and D? 
Is there a drug where L and D are not the same? 
What is UV? What is chromophore? What is Beer’s 
law? 
What is CD? What transition? 
What is fluorescence? 
What is fluorescamine quantification? 
What are resazurin? Resofurin? 
 
 
Why not polarimeter? 
How does a mass spectrometer work? 
What are they dyes? 
What is Rink? What is resin made up of? 
What is HPLC? Chromatography; mobile, station
ary phase, detector, why add TFA 
How long does it take to develop a drug? 
How can we make production of lipopeptide chap
er? 
Who is Alexander Fleming? 
Who are Chain and Florey? 
What is antibiotic? Antimicrobial?  
What is the target of penicillin? 
How is resistance in penicillin developed? 
How is resistance in lipopeptide developed? 
Why would D be more stable? What enzyme will 
cleave basic amino acids? Trypsin? Protease? 
What are the components of bacteria vs eukaryot
ic membrane? Cholesterol? 
What processes get destroyed when the membra






Questions 1  
Questions2 
Statistically significant? 
What was the peptide synthesized by Merrifield? 
What is MIC? LD50? HC50?  
What is ATCC? American Tisssue and Culture Co
llection 
What diseases are caused by E.coli and S. aureu
s? 
Can Fmoc deprotection give you yield? 
What  is the yield? 
What is pKa of orn? 
What are the requirements of lipopeptide? Hydro
phobicity balanced with hydophilicity and charge 
What is MIC iof daptomycin? 
Gram positive gram negative bacteria membrane 
and fungal? 
Why not use disc diffusion method? 
What is ATCC number? 
What is flow rate in HPLC: analytical ; semi-prep 
and preparative 
How quantify 
How calculate for materials 































Fleming’s Petri Dish  
Penicillin G  (1939) 











1943: Large-Scale Production  
of Penicillin for Military Use 
Eukaryote   vs  Prokaryote 
Making Bacterial Cell Wa
ll 
How Penicillin Works:  





Iron Man with Repulsor Beam 
Figure taken from? https://twitter.com/ultrad3 
https://www.stockunlimited.com/vector-illustration/medicine-pill-hero_2016152.html 
https://www.vectorstock.com/royalty-free-vector/pill-character-super-hero-flying-vector-17338150 




Antibiotic Resistance Ad 
You Tube 
https://www.youtube.com/watch?v=zTbLai2GaQM 
Antibiotic Resistance Ad Serius 
https://www.youtube.com/watch?v=mu7qsi0y4Mc 






•  Synthesis Ultra L 
•  Synthesis Ultra D 
2 
•  Purification: HPLC 
•  Characterization: UV; Mass 
Spectrometry; CD 
3 
•  Determine MIC E. coli 
•  Determine MIC S. aureus 
Methodology 
1 
•  Synthesis Ultra L 
•  Synthesis Ultra D 
2 
•  Purification: HPLC 
•  Characterization: UV; Mass 
Spectrometry; CD 
3 
•  Determine MIC E. coli 
•  Determine MIC S. aureus 
Results and Discussion 
GOAL : FIND NEW DRUGS 
Figure taken from: http://vir123.com/vzv-drug-resistance/ 
Rink Amide Resin 






Rink Amide Resin 































Couple with Myr 
Cleave with TFA:TIS:H2O 
H2N- 
Free     
Amine 
























Couple with Myr 





























Couple with Myr 
Cleave with TFA:TIS:H2O 
H2N- 
Coupling solution 
to activate  
























Couple with Myr 
Cleave with TFA:TIS:H2O 
H2N- 
Protected amino   
acid attached       
























Couple with Myr 
Cleave with TFA:TIS:H2O 
H2N- Bromophenol Test 
























Couple with Myr 




























Couple with Myr 
Cleave with TFA:TIS:H2O 
H2N- 


























Couple with Myr 


























Couple with Myr 



























Couple with Myr 






























Couple with Myr 
Cleave with TFA:TIS:H2O 
H2N- 
Rink amide resin 
Provides amide in C-terminal; amidated peptide cleaved from resin using 
TFA (trifluoroacetic acid) 
Figure taken from : alexandre.chapron.free.fr/combichem/solid_phase.htm 
UV of Deprotection Soln 
Fmoc Synthesis Strategy Employed 
Myr-L-(Orn)3-NH2  
Myr-D-(Orn)3-NH2  
Synthesis of Peptide 




scavenge cationic species 
TIS: triisopropylsilane 
TFA: trifluoroacetic acid 
























No free amine 
